Jump to main content
Jump to site search

Issue 44, 2011
Previous Article Next Article

Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells

Author affiliations

Abstract

New 1,2-closo- and 7,8-nido-carboranylpyrazolopyrimidines bind to the translocator protein (TSPO) with high affinity, providing the first evidence of a unique two-site binding profile for the closo-carborane derivative. The boron-rich compounds can also deliver boron to human glioma cells far more effectively than clinical agents used in boron neutron capture therapy (BNCT).

Graphical abstract: Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 Jul 2011, accepted on 20 Sep 2011 and first published on 13 Oct 2011


Article type: Communication
DOI: 10.1039/C1CC14587H
Citation: Chem. Commun., 2011,47, 12179-12181
  •   Request permissions

    Synthesis and cellular uptake of boron-rich pyrazolopyrimidines: exploitation of the translocator protein for the efficient delivery of boron into human glioma cells

    E. L. Crossley, F. Issa, A. M. Scarf, M. Kassiou and L. M. Rendina, Chem. Commun., 2011, 47, 12179
    DOI: 10.1039/C1CC14587H

Search articles by author

Spotlight

Advertisements